IL6 and cancer: (2020) evaluated that Rb1 can reduce the expression levels of key inflammatory cytokines TNF-α and IL-6 in a cancer cachexia mouse model, this finding is consistent with our experiment, indicating that Rb1 can alleviate symptoms caused by inflammation.